viewJohnson & Johnson

Johnson & Johnson receives US$2.1bn offer for LifeScan Inc. from Platinum Equity

LifeScan makes blood glucose monitoring products for people with diabetes

Johnson & Johnson logo through magnifying glass on website
A J&J executive said the possible sale is "part of our ongoing, disciplined approach to portfolio management"

Johnson & Johnson (NYSE: JNJ) said it has been offered about US$2.1bn for LifeScan Inc., a maker of blood glucose monitoring products for people with diabetes.

Johnson & Johnson said the offer is from Platinum Equity, a private investment firm. The healthcare giant said the acceptance period for the offer will end on 15 June 2018, unless extended. If the offer is accepted, the transaction should close by the end of 2018, Johnson & Johnson said.

READ: New tax law drags Johnson & Johnson’s fourth quarter into red territory but sales up

LifeScan had revenue in 2017 of about US$1.5bn. Ashley McEvoy, company group chairman, Consumer Medical Devices, Johnson & Johnson, said the possible sale of LifeScan to Platinum Equity would be "part of our ongoing, disciplined approach to portfolio management to focus on our most promising opportunities to help patients and drive growth."

LifeScan's potential sale appeared to have no impact on the shares of Johnson & Johnson, which were down just 0.6% at US$132.28 in mid-morning trading Friday.

Quick facts: Johnson & Johnson

Price: 149.5 USD

Market: NYSE
Market Cap: $393.46 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Bull, Bears & Brokers: Shaw and Partner’s Davide Bosio talks about market...

Shaw and Partners WA state manager Davide Bosio updates Proactive on how share prices plunged this week, with stock market jitters in light of the coronavirus scare. Bosio gives his advice on how investors can protect their portfolios and takes a look at solid investment options during times...

46 minutes ago

2 min read